Earnings Call · Q1 FY2026·2026-05-13

Q2 21EPS n/a·Rev n/aQ1 21EPS n/a·Rev n/aQ4 20EPS n/a·Rev n/aQ2 20EPS n/a·Rev n/a⚠ consensus missing

Humacyte, Inc. HUMAW

Thomas Johnson

Laura Niklason — President, CEO and Director

Dale Sander — CFO and Chief Corp. Deve. Off.

−9.1%1d on move date−9.7% vs SPY3d−19.3%5d−42.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more HUMAW calls or request research access.

More HUMAW calls Browse calls Request research access